FDA approves patisiran to treat hereditary transthyretin amyloidosis
Year: 2018
Type: article
Source: Nature Reviews Neurology
Author: Heather Wood
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2888899523
